AGIO - Agios Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 54.96B
Enterprise Value 34.58B
Trailing P/E N/A
Forward P/E 1-22.69
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)115.22
Price/Book (mrq)11.24
Enterprise Value/Revenue 3106.54
Enterprise Value/EBITDA 6-14.58

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Dec 31, 2017

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-745.84%

Management Effectiveness

Return on Assets (ttm)-32.51%
Return on Equity (ttm)-85.73%

Income Statement

Revenue (ttm)43.01M
Revenue Per Share (ttm)0.92
Quarterly Revenue Growth (yoy)-56.70%
Gross Profit (ttm)43.01M
EBITDA -314.36M
Net Income Avi to Common (ttm)-314.67M
Diluted EPS (ttm)-6.75
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)423.94M
Total Cash Per Share (mrq)7.39
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)4.69
Book Value Per Share (mrq)7.69

Cash Flow Statement

Operating Cash Flow (ttm)-285.23M
Levered Free Cash Flow (ttm)-147.12M

Trading Information

Stock Price History

Beta 2.53
52-Week Change 386.38%
S&P500 52-Week Change 313.44%
52 Week High 389.33
52 Week Low 345.11
50-Day Moving Average 382.62
200-Day Moving Average 371.34

Share Statistics

Avg Vol (3 month) 3473.03k
Avg Vol (10 day) 3404.42k
Shares Outstanding 557.33M
Float 49.83M
% Held by Insiders 113.22%
% Held by Institutions 187.31%
Shares Short 36.42M
Short Ratio 315.22
Short % of Float 348.51%
Shares Short (prior month) 35.9M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A